
Scientist at @TheDohertyInst @UniMelbMDHS studying Antibody Responses against Infectious Diseases, HIV, TB, Malaria, Influenza and COVID-19
Melbourne, Victoria
Joined March 2019
- Tweets246
- Following292
- Followers385
- Likes819
Amy Chung retweeted
Looking for a post doc? Interested in studying antibodies? Love working with cool people? Join the Chung lab now ✨️ @AmyWChung #postdoc jobs.unimelb.edu.au/en/job/9…
Chung lab @TheDohertyInst @UniMelbMDHS is looking for an enthusiastic postdoc to research antibodies against infectious and autoimmune diseases. Please distribute! jobs.unimelb.edu.au/en/job/9…
Amy Chung retweeted
Just in time for #ARVO2024 - Our paper 'Intravital imaging of the human cornea reveals the differential effects of season on innate and adaptive immune cell morphodynamics' - online today in Ophthalmology aaojournal.org/article/S0161…
Amy Chung retweeted
Check out our study on: Seasonal flu vaccines prior to the 2009 pandemic in children to assess antibody correlates of protection. Great collaborations between @Janice_ZRJia @GuHaogao and Carolyn Cohen, leveraging RCT of @bencowling88 @gmleunghku and systems serology @AmyWChung
Chung Lab @TheDohertyInst @UniMelbMDHS is hiring a research assistant to help profile antibody responses against infectious diseases including COVID, Influenza, TB and HIv Please share! Applications close 20 Feb. jobs.unimelb.edu.au/en/job/9…
Amy Chung retweeted
Very excited to share our latest paper! 🥳
We started this project right before the pandemic began, and like many things, was put on hold. Now, after 4-years I’m happy to announce the teams work is finally out!
1/3
Haycroft et al examined humoral response to SIV-𝘔𝘺𝘤𝘰𝘣𝘢𝘤𝘵𝘦𝘳𝘪𝘶𝘮 𝘵𝘶𝘣𝘦𝘳𝘤𝘶𝘭𝘰𝘴𝘪𝘴 coinfection using cynomolgus macaque and concluded that antibody glycosylation correlates with TB disease progression.
@ASImmunology @WileyGlobal
onlinelibrary.wiley.com/doi/…
Great work by @EbeneRHaycroft that demonstrates how antibody glycosylation early in SIV-TB infection is a biomarker for TB disease progression @TheDohertyInst @UniMelbMDHS
Haycroft et al examined humoral response to SIV-𝘔𝘺𝘤𝘰𝘣𝘢𝘤𝘵𝘦𝘳𝘪𝘶𝘮 𝘵𝘶𝘣𝘦𝘳𝘤𝘶𝘭𝘰𝘴𝘪𝘴 coinfection using cynomolgus macaque and concluded that antibody glycosylation correlates with TB disease progression.
@ASImmunology @WileyGlobal
onlinelibrary.wiley.com/doi/…
Amy Chung retweeted
Very proud of Jack, @liamckealy, @HuiXu47534424: here they step thru their concept, design & exhibit of tactile models for ppl w/ low vision & diverse needs
🙏@ETandori @RossjohnLab for @MonashUni Sensory Science & @jessborger for @ImmunolCellBiol series
onlinelibrary.wiley.com/doi/…
Amy Chung retweeted
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections: buff.ly/3PDOh9a
@ProfStephenKent @AmyWChung @TheDohertyInst
#COVID_19
Two new studies by @Kev_in_Science exploring mucosal antibodies upon mRNA breakthrough infection @JCI_insight insight.jci.org/articles/vie… & AstraZeneca vaccines @ImmunolCellBiol onlinelibrary.wiley.com/shar…. Mucosal but not plasma IgA induced by hybrid immunity is cross reactive to VOCs
Many thanks to everyone who contributed to this work @viralvaxlab @EbeneRHaycroft @CheeWahTan2 @DrLauraDownie @SamanthaKDavis1 @RuthAmyPurcell @TheDohertyInst @UniMelbMDHS @KirbyInstitute and many others!
1
2
203
@Kev_in_Science describes these studies in greater detail:
Replying to @Kev_in_Science
To learn more about our findings on mucosal antibodies, here's our 🧵 😉
teapaw.org/Kev_in_Science/status/…
2
286
Amy Chung retweeted
New research shows mucosal surfaces in eyes, nose, mouth and throat are crucial to the first line of defence against upper respiratory infections, like #COVID19.
Published in @JCI_insight @ImmunolCellBiol
doherty.edu.au/news-events/n…
@UniMelbMDHS @TheRMH @Kev_in_Science
Amy Chung retweeted
How does antiviral immunity against #influenza evolve across human lifespan? 👶➡️👧➡️👱➡️👵
Our study in @NatImmunol investigates differences in CD8 T cell response across human lifespan-a🧵⬇️ go.unimelb.edu.au/627s
@CvandeSandt @KatherineKedz @FabioItaus @TheDohertyInst (1/21)
Congratulations to @SamanthaKDavis1 for her SARS-CoV2 IgA paper being awarded the 2022 CTI @ClinTransImmuno Publication of the year! Thanks to many collaborators including @tham_lab @viralvaxlab @Kev_in_Science @EbeneRHaycroft @TheDohertyInst
Congratulations to Davis et al for being awarded the 2022 CTI Publication of the Year Award.
This award consists of AUD$1000 and an opportunity to speak at the next ASI meeting in December and free registration.
@ASImmunology @WileyGlobal @SamanthaKDavis1
onlinelibrary.wiley.com/doi/…
Amy Chung retweeted
Interested in Honours or Masters study at @TheDohertyInst? Join us at our information session to hear from course coordinators and current students.
Wed 30 AUG, 4.30pm
📍Doherty Institute Auditorium
eventbrite.com.au/e/doherty-…
@UniMelbMDHS @UniMelb @TheRMH
Amy Chung retweeted
It's official! I Am Dr Sam 👩🔬! Huge thanks to everyone who made this possible, especially my supervisors @AmyWChung and @ProfStephenKent and all the lab members who made the journey a little bit easier 💙 #phdgrad #unimelb
Amy Chung retweeted
Please RT!
🎉 Excited to be starting a joint appointment @BiologyANU @ourANU 🎊- will be looking for a lovely #StructuralBiologist to join our lab. If you are interested in infectious diseases, nanobodies and have trail runnjng suggestions, please reach out! 🦙 🦙 @CanberraPG
Amy Chung retweeted
More than 70 years is beyond long overdue, but its good to see progress towards justice and recognition for Henrietta Lacks and her family.
thebaltimorebanner.com/econo…
Amy Chung retweeted
What are the dynamics and durability of neutralizing antibody responses after Omicron BA.1/BA.2 infection?
Our new study from @WenShiLee @Hyonxhi @scientist_JJ @WheatleyAtotheK @ProfStephenKent and team tries to scratch the surface of this.
science.org/doi/10.1126/scia…
















